MedicalDiagnostics India Medical Diagnostics India

April2009

ExecutiveSummary
MedicalDiagnosticaccountsfor10%ofthehealthcareindustryinIndia Diagnosticsmarketcomprisesof
DiagnosticServicesMarket:EstimatedatINR37.9bnin2008 DiagnosticProductsMarket:EstimatedatINR15.8bn2008

Market

Indiahasmorethan40,000laboratories

Drivers& Challenges g

Drivers:Increaseinlifestylerelateddiseases,changingdemographics,growthinmedical outsourcing,medicaltourism,nascentbutgrowingmedicalinsurance,risingPE/VCinvestments Challenges:DifferenceinimportdutyondiagnostickitsforpublicandprivatesectorandLackof accreditation/certificationofdiagnosticcenters Diagnosticequipmentsmarketisregulatedbybothcentralandstategovernment MajorgoverningauthoritiesincludeDirectorateGeneralofHealthServices,IndianFoodandDrug g g g Administration,CentralDrugsStandardControlOrganization,DrugControllerGeneralofIndia Regulatoryprocessfordiagnosticsequipmentissegmentedinto

Critical ProductsusedforthediagnosisofHIV,HBsAg,HCV,Bloodgroupingreagents,malariatests Noncritical Otherdiagnosticsproducts

Rulesand Rules and Regulations

Manufacturersneedanimportlicenceandproductregistrationcertificatetoimportdiagnostic equipments Diagnostictestservicesmarketishighlyfragmentedwithmanyunorganizedplayers

Competition

SomeofthemajorplayersareMetropolisHealthServices,SRLRanbaxy,PiramalDiagnostics,DrLalPathLabs, Thyrocare,ApolloHospitals

Foreign players (like Roche Abbott J&J ) account for 64% share in diagnostic equipment market Foreignplayers(likeRoche,Abbott,J&J )accountfor64%shareindiagnosticequipmentmarket
SomeofthemajordomesticmanufacturersareTransasia,TulipGroupandAgappeDiagnostics

MEDICALDIAGNOSTICS INDIA.PPT

 MarketOverview Drivers & Challenges Drivers&Challenges Rules&Regulationsfor Manufacturers/Suppliers Competition K D l KeyDevelopments t

MEDICALDIAGNOSTICS INDIA.PPT

Indiandiagnosticsmarketiswitnessingsignificantgrowthwith majorcontributionfromtheInVitroDiagnostic(IVD)segment
MarketOverview
Indiandiagnosticmarketcomprisesof
Diagnostictestservicesmarket Diagnosticproducts/instrumentsmarket

DiagnosticTestServicesMarket
INRbn
40 30 20 10 0 26.3

+20%
37.9 31.6 31 6

Diagnosticmarketaccountsfor10%ofhealthcare sector Indiacurrentlyhasover11,500hospitalsand40,000 diagnosticlaboratories diagnostic laboratories About70%ofthetreatmentsinIndiaarebasedonlab diagnostictests

In2008,IVD servicesmarket wasINR36bn 2006 2007 2008

Marketsizeestimationisdifficultasdiagnosticmarketishighlyunorganized

IVDTestSegments(2008)
BioChemistry
5% 6%

IVDInstruments&ReagentMarket
INRbn
20 15 10 5 0 11.4 11 4

4% 3% 37%

Immunology Haematology Criticalcare UrineRoutine Others Microbiology

+18%
12.8

15.8

7%

14%
24%

Coagulation

2006

2007

2008

MEDICALDIAGNOSTICS INDIA.PPT

Technologicaldevelopmentshasledtothediagnosisofawide spectrumofinfectiousdiseases
Diagnostics
Tuberculosis HIV Malaria HepatitisB HepatitisC Dengue D Syphilis Typhoid

Consumption&trends
InfectiousDisease
Increasing Increasing Increasing Steady Steady Steady S d Steady Steady

Typeoftesting
ELISA90%;Rapid10% ELISA65%;Rapid35% d Immunodiagnosticm ELISA65%;Rapid34%Agglutinationmethods1% ELISA80%;Rapid20% ELISA65%;Rapid35% ELISA 65% R id 35% ELISA65%;Rapid35% ELISA65%;Rapid35%

CAGR%(200408)
11.0 10.6 9.4 7.7 7.7 7.6 76 5.7 5.6

Hormones
Reproductivehormones Thyroid Increasing Increasing ofLH35%,FSHandprolactinkits65% ELISA90%,RIAandChemiluminescence10% 8.6 7.7

Others
BloodGroupingreagents Pregnancydiagnosis CancerMarkers Steady Steady Steady Haemagglutination Immunochromatography/Latex Fluorescence,ELISA,Chemiluminescence 5.7 5.7 5.7

MolecularDiagnostics

Nascentmarket.MaximumpenetrationobservedonlyinPolymeraseChainReaction(PCR)basedtechnologies. Companiesofferingimmunodiagnosticshavebeenlargelyimportingequipments

Thisshowsthatthemarketfordiagnostictestshasbeenrising

MEDICALDIAGNOSTICS INDIA.PPT

 MarketOverview Drivers & Challenges Drivers&Challenges Rules&Regulationsfor Manufacturers/Suppliers Competition K D l KeyDevelopments t

MEDICALDIAGNOSTICS INDIA.PPT

Drivers&Challenges

Drivers
Increaseinlifestylerelateddiseases Changingdemographics Growthinmedicaloutsourcing RapidgrowthofIndiaasadestination Rapid growth of India as a destination formedicaltourism Increasingpenetrationofmedical insurance RisingPE/VCinvestments

Challenges
Differenceinimportdutyon diagnostickitsforpublicandprivate sector Lackofaccreditation/certificationof / diagnosticcenters

MEDICALDIAGNOSTICS INDIA.PPT

Mountinginstancesoflifestylediseasesinurbanareasandthe demandforqualitydiagnosis
Growthinlifestylerelateddiseases
Increasinginstancesoflifestylediseasesisanurbanphenomenon,especiallyamongtheyoung andworkingclassinmetropolitanareas Lifestylediseasessuchascardiacailments,diabetesetc.requireexpensivediagnostictests makingthissegmentincreasinglylucrativeforplayers

Impact

PrevalenceofchroniclifestylediseasesinIndia P l f h i lif t l di i I di
% of Population 4.91% 5
4 3 2 1 0

DiagnosticTestsCostComparison Di ti T t C t C i
USD/Treatment
500 400 300 200 150 12 5 100 0 280 418

2005 2015 3.70% 2.80%

3.31%

0.18% 0.20% 0 18% 0 20% Cardiac Diabetes Cancer

Hepatitis Thyroid Cardiac Diabetes Cancer A

MEDICALDIAGNOSTICS INDIA.PPT

ChangingdemographicscenarioinIndiaisexpectedtodrive demand
Changingdemographics
Increaseinaveragelifeexpectancyandgrowthinelderlypopulationisexpectedtoboost demand Largescalemovementofruralpopulationtourbancenterswillalsooptfortheseservices AverageLifeExpectancy
years
100 63.3 50 0 65.1 66.0

Impact

Population(Age65yearsandabove)
%
6 4 2 0 4.7 5.3 5.8

2000-04

2005-09

2006-10

2000

2005

2010

MEDICALDIAGNOSTICS INDIA.PPT

Strongoutsourcingopportunitiesduetotechnological enhancementsandcostbenefits
Growthinoutsourcing
Diagnosticsoutsourcinghasbeengrowingduetotechnologicalupgradationofequipmentin Indianlaboratoriesmeetinginternationalstandards Costbenefitshavealsoplayedamajorrole Specializedtestslikemoleculardiagnosticsorhormonerelatedtestscost7080%lessinIndia thaninUS MedicalinstitutionsfromUSandUKhavebeenoutsourcingabulkoftests
OutsourcingopportunityspecificallyfromtheUK,inhealthcaresector,ispeggedataroundUSD800mn

Impact

Indiaprovidescostarbitrage:
Tests Bloodtests,X raysandultrasounds Blood tests, Xrays and ultrasounds Magneticresonanceimaging(MRI)scan Thyroidprofilebloodtest Note:Theratesareindicative CostinUS/UK(USD) 574 700 3050 CostinIndia(USD) 84 60 5 %Difference 583 1067 500900

MEDICALDIAGNOSTICS INDIA.PPT

10

Medicaltourismisprovidingsupplementalrevenuesforthe diagnosticmarket
MedicaltourisminIndia
Inadditiontogrowingdomesticdemand,medicaltourismisgeneratingadditionalrevenuefor diagnosticsservices Medicaltourismhasbeengrowingat30%andisexpectedtobecomeatUSD2bnindustryby 2010 Somepartofmedicaltourismmarketisexpectedtoaccruetothediagnosticsmarket,primarily benefitingthehospitalswithdiagnosticcenters M i d i Maindriversandchallengesformedicaltourismare d h ll f di l t i
Drivers Significantsavings Worldclassfacilities Qualityandexperienceofmedicalprofessionals Minimalwaitingtime Largemarketofuninsuredindevelopedcountries Challenges Inadequateairconnectivity Visarequirementsfrommostcountries q Medicolegaljurisdictions Countryspecificrestrictions

Impact

MEDICALDIAGNOSTICS INDIA.PPT

11

Growingpenetrationratesofhealthinsurancehasmadequality diagnosticservicesmoreaffordable
Risinghealthinsurancelevels
InIndia,penetrationofhealthinsuranceisverylowbutgrowing:
Morefamiliesfrommiddleclassarenowpurchasinghealthinsurance 20%ofpopulationislikelytohavemedicalinsuranceby2015comparedtocurrent2% Additionally,manycompaniesareprovidinghealthinsurancecoveragetoemployees therebydrivingpenetration

Impact

Increasinginsurancecoverageprovideadditionalrevenuetothediagnosticscentres g g p g
Insurancecompaniestieupwithdiagnosticcentrestoprovidebetterhealthassessment services(medicalscreening,diagnostictesting)tolifeinsurancecandidates
BirlaSunLifeInsuranceCompanyLtdenteredintoapartnershipwithQuestDiagnosticsIndiaPrivateLtd. ICICILombardenteredintoaninsurancepartnershipwithManipal,FortisandApolloGroup

HealthInsurancePremium
INRbn
1,000 500 212 47 0 950

+35%

2008

2013

2018

MEDICALDIAGNOSTICS INDIA.PPT

12

LargescaleinvestmentsfromPE/VCfirmstowardscapitalizing onthegrowthprospectsinthemarket
IncreasedfocusofPE/VCfirms
PrivateequityplayersarebullishonthehealthcareindustryinIndia In2008,thehealthcaresectoraccountedfor13%oftotalinvestmentsamountingtoUSD 5570.48mn Apartfromhospitalsandpharma,privateequityplayersarealsoshowinginterestindiagnostic centersinIndia Date D t Nov2007 2007 Jun2006 May2006 2005 Investor I t ePlanetVenturesandHSBC PrivateEquity(Asia)Ltd SequoiaCapitalIndia Sequoia Capital India Bennett,ColemanandCo. ICICIVentures SequoiaCapitalIndia q p Trivitron DrLalPathLabs Dr Lal PathLabs Thyrocare MetropolisHealthServicesLtd DrLalPathLabs Target T t % Stake n.a. n.a. na n.a. n.a. 26 Amount USDmn 11 4 n.a. 8 6

Impact

MEDICALDIAGNOSTICS INDIA.PPT

13

Biasedgovernmentregulationandthelackofaccreditation affectingtheofqualityservicesarethemajorbarriers
Differenceinimportdutyondiagnostickitsforpublicandprivatesector
Theimportstructurehasbeensoformulatedthatitfavorsthepublicsector Privatesectorisfacedwiththeissueofprovidingservicesatcompetitivepricesacrossincome groupsandareoftenreducedtoprovidingservicesonlytoanichemarket
Public Inordertoimportequipmentsandreagents Government hospitals do not require a an import Governmenthospitalsdonotrequireaanimport license;adutyof5%islevied Equipmentandsuppliesareprocuredthrough tenderswithpricebeingtheforemostbasisof decisionmaking Private Forimportingdiagnosticequipmentsadutyof19.8 21.7%islevied Equipmentsandsuppliesareprocuredbasedon qualityandprice,leadingtocostescalations

Impact

Lackofaccreditation/certificationofdiagnosticcenters
Lackofaccreditationorcertificationhasledtoalargepoolofmedicalcenterswithminimal g p focusonthequality,whichisincontrasttomandatoryrequirementsforotheraspectsof

Impact

healthcaresuchashospitals,doctors,nursesandevenpharmacies
Lessthan1%ofthetotallaboratoriesareaccredited
14haveCollegeofAmericanPathologists(CAP)accreditation 45haveNationalAccreditationBoardofLaboratories(NABL)accreditation

MEDICALDIAGNOSTICS INDIA.PPT

14

 MarketOverview Drivers & Challenges Drivers&Challenges Rules&Regulationsfor Manufacturers/Suppliers Competition K D l KeyDevelopments t

MEDICALDIAGNOSTICS INDIA.PPT

15

Diagnosticequipmentmanufacturersarehighlyregulatedbythe centralandstategovernmentbodies
Majorgoverningbodies
GovernmentAuthorities
TheDirectorateGeneralofHealthServices FDAandCDSCO DrugControllerGeneralofIndia Drug Controller General of India Statedrugoffices/StateFDAs

Operation
OverseesactivitiesoftheIndianFoodandDrugAdministration(FDA)andCentralDrugs Oversees activities of the Indian Food and Drug Administration (FDA) and Central Drugs StandardControlOrganization(CDSCO) Regulatesthemanufactureofalldiagnostickitsandreagentsasitbelongstothe categoryofdrugs Responsibleforapprovaloflicensesofspecifiedcategoriesofdrugsanddiagnostics products Theymonitorthequalityofdrugsanddiagnosticsproductsthataremanufacturedby respectiveStateunitsandthosemarketedintheState

Segmentationofproducts
CriticalDevices DiagnosticProducts Diagnostic Products Productsusedforthe diagnosisofHIV,HBsAg, HCV,Bloodgrouping reagents,malariatests

NonCriticalDevices

Otherdiagnosticsproducts

AlldiagnosticsproductsmanufacturedorsoldinIndiarequiresalicense

MEDICALDIAGNOSTICS INDIA.PPT

16

Thedifferenceinregulationsforcriticalandnoncritical diagnosticsdeviceshasledtolackofqualitycontrol
Regulatoryprocessfordiagnosticsequipments
Applicationis A li ti i submittedtothe DrugsController GeneralofIndia Quality checksare conducted by y National Institute of Communica ble 36months disease Manufact uring license li granted afteran auditof manufact uringunit

CriticalDevices

NonCriticalDevices

Testmanufacturinglicenseortestbatchevaluationisnotrequired Noinspectionsneedstobecarriedoutbythecentralauthorities The application is to be filed only with the State drug offices TheapplicationistobefiledonlywiththeStatedrugoffices

Lackofsufficientqualitycontrolmeasureshasledtosubstantialnumberofquestionableproductsinthemarket

MEDICALDIAGNOSTICS INDIA.PPT

17

Manufacturersneedanimportlicenseandproductregistration certificatefromtheCentralDrugsStandardControl
RegulationsRelatedtoImports
CDSCOisresponsibleforqualitycontrolofimportedproductsaswellasthelicensingofnewproducts

RegistrationCertificate
RegistrationCertificate:Applicationinrespectofthe premisesandthedevicestobeimported Submission: TheapplicationisreviewedbytheDrugs ControllerGeneral Registrationfee:USD1000perproducttoberegistered OtherDocuments:Bankslipsshowingrequisitefeepaid,Form 40PowerofAttorneytotheIndianAgent/Officeanddossiers Duration:Theregistrationprocesstakes9months Forwardedbythemanufacturer,importerortheagentin India

ImportLicense
Documentation Form9istobeforwardedbythemanufacturerandshouldbe attestedbytheIndianEmbassyinthemanufacturerscountry GMP(GoodManufacturingPractices)certificate CompanyRegistrationcertificate FreeSalesCertificateinthecountryofmanufacture Manufacturing License ManufacturingLicense CountryofOriginCertificate Listofcountrieswheretheproductisalreadybeingexported ISO/TUV/CEcertificate BatchReleaseCertificate(foranyonebatch) QCcertificates(foranyonebatch)

Otherrequirementsforimportedmedicaldiagnosticequipmentsare Abatchreleasecertificateforthespecificgoodsthathavebeenimported Shelflifecertificatewhichmuststatethatthegoodshaveashelflifeofmorethan60%atthetimeoflanding g g CertificateofAnalysisfortheproductssupplied

MEDICALDIAGNOSTICS INDIA.PPT

18

Customdutyisleviedonthediagnosticequipmentsimported
Importdutystructure
TheGovernmenthasbeenfocusingonenhancingprivatesectorparticipationbyreducingthe customsdutyleviedonimportsofdiagnostickitandreagentsimportedbytheprivateplayers
%
40 30 20 10 0 34.4 34.5 21.7 19.8

Pregnancy confirmation reagents/Reagents for diagnosing AIDS/Others Diagnostic reagents designed to be administered to the patient/Blood grouping reagents

Jan 2008

Feb 2009

MEDICALDIAGNOSTICS INDIA.PPT

19

 MarketOverview Drivers & Challenges Drivers&Challenges Rules&Regulationsfor Manufacturers/Suppliers Competition K D l KeyDevelopments t

MEDICALDIAGNOSTICS INDIA.PPT

20

Organizedpathlabsarerapidlyexpandingusingthehuband spokemodel,includingsmall,independentlabsinthenetwork
DiagnosticTestingMarketStructure
Highlyfragmentedwith~40,000laboratories:
Hospitals:43% Independentlabs:52% CC Reference Lab Satellite Satellite Lab CC Satellite S t llit Lab

HubandSpokeModel
CC CC CC

AmongthelabsinIndia
Automated 5% Semi Automated 38% Manual 58% Manual 58%

Organizedplayersaccountfor10%ofmarketand expandingwithhubandspokemodel:
Referencelabsactasregionalhubsandareusuallylocated inlargemetros Collectioncentresarelocatedinhospitals,nursinghomes, pathologylabs,doctorsclinicsetc. Satellitelabsandcollectioncentresareeitherownedor franchised

CC

CC

CC

As organized players grows their share small Asorganizedplayersgrowstheirshare,small, independentlabsare:

Becomingfranchiseesinthehubandspokemodel Partneringwithlargechainsonreferralbasis Gettingacquiredbylargechains,whichlowersthecostof expansionandstartuptimeforthelatter

Referencelabs:Hubwithcomprehensiveorspecializedtesting capability Satellite labs: Limited testing capability; feedreferencelabs Satellitelabs:Limitedtestingcapability; feed reference labs Collectioncentres(CC):Collectsamplesforforwardingto eitherasatellitelaborreferencelab Avariationinthismodelistheabsenceofsatellitelabsand theexistenceofonlyreferencelabsandcollectioncentres

MEDICALDIAGNOSTICS INDIA.PPT

21

MajorPlayers DiagnosticTestServicesMarket(1/2)
Company ApolloHospitals Overview
Startedin1983 DiagnosticfacilitiesintheirsubsidiaryApolloClinics Facilities allow for investigation in Biochemistry Haematology FacilitiesallowforinvestigationinBiochemistry,Haematology, ClinicalPathology,Microbiology,Xray,UltrasoundwithColor Doppler,ECG,EchoCardiographyandTreadmill Startedin1977 40labsand500samplecollectioncenters Accreditation:NABL,CAP

BusinessOutlook
EnteredintoaJVwithAmcareLabs,an affiliateofJohnsHopkinsInternationalof theUS,tosetupadiagnosticlaboratoryin HyderabadataninvestmentofUSD2.2mn Establishedaninternationalalliancewith QuestDiagnosticsNicholasInstitutefor testing Planningtosetup50labsand1000 collectioncentersby2012 Expandoperationsinsouthernandwestern regionsinvestingINR600mn PlanningtoinvestINR100mninbrand l b d building Growinginorganically Itislookingatoverseasexpansionaswellas outsourcingopportunities g pp Plansonincreasingtheirportfolioto9more labs TargetedrevenueofINR5bnby2010 In2008,acquiredtwolabsinNorthIndia andamajoritystakeinBangalorebasedRV and a majority stake in Bangalore based RV DiagnosticLaboratory

DrLalPathLabs

MetropolisHealth Services

Startedin1981 10000laboratoriesacross125citiesglobally,13laboratoriesin India,350collectioncenters , Capabilitytocarryover3600routineinvestigationswithover 100technologies e.g.biochip,DNAsequencing,pathology, radiology ICICIVenturesowns18%ofthecompany Accreditation: CAP NABL Accreditation:CAP,NABL

Note:Thislistisnotexhaustive

MEDICALDIAGNOSTICS INDIA.PPT

22

MajorPlayers DiagnosticTestServicesMarket(2/2)
Company Overview BusinessOutlook
PlanningtoinvestINR2.5bntoexpandits diagnosticchainin75urbancentersby2010 AcquiredMinradInternationalIncforUSD q 40mn TieupswithUKbasedorganizationsfor outsourcing Plansondeveloping23reference laboratoriesin2009 ExpansionbudgetispeggedatINR1.5bn In2008,acquiredDubaibasedMena HealthcareforUSD20mn Centralizedoperationsthroughasingle laboratorymodel,locatedinNaviMumabi Onlyplayerexpandingthrougha100% franchiseemodel

PiramalDiagnostics Startedin1988 104diagnosticcentersin48cities,300collectioncenters /Wellspring

Carries out over 1500 tests Carriesoutover1500tests Accreditation:NABL,CAP

SuperReligare Laboratories Limited/SRL / Ranbaxy

Startedin1996 35labs,800collectioncentersdistributedin400townsacross thecountryand7franchiseelab Catersto25000doctors,650hospitalsand~1000smaller pathologylabsandcarriesout34000tests/daybasedon95 technologies Accreditation:CAP,NABL,CLSI,GCLP ReportedtotalrevenuesofINR804mninFY2007 p Startedin1995 Carriesout30000test/day,over600franchisedcollection centers Accreditation:CAP,NABL

Thyrocare

Note:Thislistisnotexhaustive

MEDICALDIAGNOSTICS INDIA.PPT

23

Manufacturers IVDProducts/InstrumentsMarket
Playersinthemarket
TheIVDproductsmarketinIndiaisprimarily y g p dominatedbyforeigncompanies GlobalIVDcompanieslikeRocheDiagnostics, Abbott,J&J,SiemensHealthcareDiagnostics, BeckmanCoulterhavestrongpresenceinthe Indianmarket I di k t Domesticplayershaveforayedintothemarket andareestablishingthemselvesbyproducing q yg costeffectiveandqualitygoods 60%ofdiagnosticmedicalequipmentand suppliesisimported Lowcostreagentkitsarebeingimportedfrom China,Taiwan,andKorea
36%

IVDProductsMarketShare(2008)

64%

ForeignPlayers DomesticPlayers

MEDICALDIAGNOSTICS INDIA.PPT

24

MajorDomesticPlayers DiagnosticEquipmentManufacturing Market(1/3)

Company AgappeDiagnostics Overview
Reagents:Clinicalchemistry,SyReBiochemistry),SyRe (Immunoturbidimetry),Controls/Calibrators,serology, hemoscreen,coagulation,Urinalanalyzer,infectiousrapidcard test,infectiousELISA,hepatitismarkers,torchpanel, Glucometer Instruments:ClinicalChemistryAnalyzer,HematologyAnalyzer, CoagulationAnalyzer,Sodium&PotassiumAnalyzer

BusinessOutlook
Focusingontheexportmarketswithplans ofestablishingasubsidiaryinDubaiunder AgappeMiddleEastLLC AlsoplanstoexpandoperationstoAfrica andEurope LaunchedBiolis12i,afullyautomatic analyseraswellasCystatinC,amore sensitiveinstrumentfortheestimationof GlomurularFiltrationRate FocusesonPointofCare(POC)for infectiousdiseaseslikeHIVandmalaria Massproductionataffordableprices Partnered with WHO for product sales PartneredwithWHOforproductsales MarketleaderinHIVdiagnosisequipment FocusesonPOCsforinfectiousdiseases Massproductionataffordableprices Partnered with WHO for product sales PartneredwithWHOforproductsales

J.Mitra

Rapidtestkits:HIVrange,HCVrange,HBVrange,Malaria range ELISAtestkits:HIVrange,HCVrange,HBVrange,Dengue range,LEPTOrange,TBrange range LEPTO range TB range ConfirmatoryTests,BloodGroupingRange Fertilityrange,Infectiousdiseasesrange, Parasitologyrange

OrchidBiomedical Systems(Tulip Group)

Note:Thislistisnotexhaustive

MEDICALDIAGNOSTICS INDIA.PPT

25

MajorDomesticPlayers DiagnosticEquipmentManufacturing Market(2/3)

Company RFCL Overview
IVD,animalhealthcare,laboratorysolutionsandcustom synthesis

BusinessOutlook
Adoptedaninorganicgrowthpath
InApril2008,acquiredBremerPharma InSeptember2008,acquiredUSbased MallinckrodtBakerforUSD340mn InJanuary2008,acquiredGodrejMedical DiagnosticsandAlvedPharma&Foods InJuly,2007acquiredWiproBiomedical

TargetedrevenueofINR5bnby2010

SpanDiagnostics Ltd.

Diagnosticreagents&kits:Bloodbankingproducts,clinical chemicalreagents,hematology,infectiousdiseasesserology, histopathology,antibioticdiscs Instruments:Biochemistry,ELISA,Hematology, Chemiluminescence Relatedtobiochemistry,hematology,urineanalysis, coagulation,ESR,immunology,liquidhandlingsystem ImmunologyReagents,CardiacMarkers,CancerMarkers, Parasitology&InfectiousDiseaseRange Parasitology & Infectious Disease Range Instruments Coagulometers,ELISAreader&washer

ItisaleaderinSphilisandthyroiddiagnosis equipment

TransasiaBio Medicals TulipGroup

Planstoexpanditsexistingproductrange andventureintomicrobiologyand veterinaryscience Itisoneoftheleadersinsyphilis,typhoid, malaria,reproductivehormones,blood malaria reproductive hormones blood groupingreagents,cancermarkersand tuberculosisdiagnosticequipment

Note:Thislistisnotexhaustive

MEDICALDIAGNOSTICS INDIA.PPT

26

MajorDomesticPlayers DiagnosticEquipmentManufacturing Market(3/3)

Company Xcyton Overview
Immunodiagnostickits:HIVCheXandHEPCheXC,JEVCheX, CYSTI CheX,Dengue CheX Moleculardiagnostickits g

BusinessOutlook
StrategicpartnershipwithQualigensfine chemicalsinordertomarkettheirHIV andhepatitisdiagnostickits p g

YashrajBiotech

Antigens:Customizedmonoclonalandpolyclonalantibodies

Focusingonreducingcostsofmolecular diagnosticsthroughinnovativetechnology diagnostics through innovative technology

OtherPlayer: AccurexBiomedical,BhatBiotech,MedsourceOzoneBiomedicalsPvt.Ltd.,Trivitron

Note:Thislistisnotexhaustive

MEDICALDIAGNOSTICS INDIA.PPT

27

 MarketOverview Drivers & Challenges Drivers&Challenges Rules&Regulationsfor Manufacturers/Suppliers Competition Ke De elopments KeyDevelopments

MEDICALDIAGNOSTICS INDIA.PPT

28

KeyDevelopments
Date
17Mar09

Development
RocheDiagnostics,aswissbasedcompany,plansonconsolidatingtheirpositionintheIndianmarketin2009.Theyplanon expandingtheirreachthroughinnovativediagnostictestssuchastheNTproBNPandKRASmutationtestsrelatedto colorectalcancer. AlokaTrivitronMedicalTechnologies,amedicalequipmentmanufacturingJVofAloka,JapanandTrivitronhealthcarebegan productionofAlokaSSD500,portableultrasoundscannerfromitsfacilityatPoonamalleeinChennai.Itplansondeveloping highqualityproductsonacosteffectivebasiscateringprimarilytothedevelopingnations. WiproanITgianthasenteredthemedicaldiagnosticsmarketthroughitssubsidiaryWiproBiomed.Theyhavetiedupwith GEtodevelopcuttingedgetechnologyinordertogenerateauniquesellingprice.Wiproisplanningtofocuson GE to develop cuttingedge technology in order to generate a unique selling price Wipro is planning to focus on telemedicine,especiallyinthediagnosticradiology. SnehaDiagnosticsplansondeveloping10stateoftheartmedicaldiagnosticscentresacrossAndhraPradeshby2009.A capitalinvestmentofINR50mnisexpectedtowardsthisexpansionventure. RFCLLimited,anICICIventurecompanyacquiredGodrejMedicalDiagnostics.ThisledtopartnershipswithQBCDiagnostics, USA,AsiaGenCorporation,TaiwanandUritestMedicalElectronicCoLtd,Chinaallowingthemtoexpandtheirreach. USA Asia Gen Corporation Taiwan and Uritest Medical Electronic Co Ltd China allowing them to expand their reach

10Feb09

06Oct08

10Mar08 09Jan08

MEDICALDIAGNOSTICS INDIA.PPT

29

Thankyouforyourtime
Foranupdatedreportoranycustomizedresearchrequirements,pleasecontact: GauravKumar
EMail: gaurav.kumar@netscribes.com;sales@netscribes.com Phone: +913340646214;+919830309715

NetscribesServices:
RESEARCH&ANALYTICS RESEARCH & ANALYTICS InvestmentResearch EnterpriseMarketResearch PatentResearch SyndicatedMarketResearch S di t d M k t R h MARKETINTELLIGENCE MARKET INTELLIGENCE MarketMonitoring&Competitive Intelligence Sales&ProspectIntelligence Listening&MediaMonitoring Li t i & M di M it i BrandSurveillance CONTENTSOLUTIONS CONTENT SOLUTIONS SocialMediaMarketing MarcomSupportServices ContentManagementServices BookPackagingServices B kP k i S i

Forfurtherdetails,visitusat:www.netscribes.com
AboutNetscribes NetscribessupportstheorganicandinorganicgrowthobjectivesofglobalcorporationsthroughacombinationofEnterpriseMarket, Investment&PatentResearch,Market&SalesIntelligence,SocialMediaMonitoring&ManagementandCustomPublishingsolution. Disclaimer:Thisreportispublishedforgeneralinformationonly.Highstandardshavebeenusedforpreparingthismarketresearchreport; Disclaimer: This report is published for general information only High standards have been used for preparing this market research report; however,Netscribes,Inc.orNetscribesisnotresponsibleforanylossordamagearisingfromuseofthisdocument.Thisdocumentisthesole propertyofNetscribesandpriorpermissionisrequiredforguidelinesonreproduction.
MEDICALDIAGNOSTICS INDIA.PPT

30